Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Galectin 3 ELISA Kit (AC3904)
Cat.#: ASET-2493
Specifications
Description Human Galectin 3 ELISA Kit allows for the in vitro quantitative determination of human Galectin 3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1387 Human beta 1 Adrenergic Receptor ELISA Kit (AC2798) Quantitative inquiry ASET-1849 Mouse PTN ELISA Kit (AC3260) Quantitative inquiry ASET-1045 Human CYP1B1 ELISA Kit (AC2456) Quantitative inquiry ASET-1514 Human Slit3 ELISA Kit (AC2925) Quantitative inquiry ASET-1721 Rat Mitofusin 1 ELISA Kit (AC3132) Quantitative inquiry ASET-2047 Mouse CaSR ELISA Kit (AC3458) Quantitative inquiry ASET-1911 Mouse c-Fos ELISA Kit (AC3322) Quantitative inquiry ASET-1550 Human TAS2R38 ELISA Kit (AC2961) Quantitative inquiry ASET-1980 Human Serine Racemase ELISA Kit (AC3391) Quantitative inquiry ASET-1450 Human KCC2 ELISA Kit (AC2861) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket